News

Demis Hassabis, CEO of Google DeepMind, hinted Tuesday evening that Veo 3, Google’s latest video generating model, could ...
Beware the tech leaders making grandiose statements about artificial intelligence. They have lost sight of reality, says ...
Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology drugs. In an interview with Fortune, Isomorphic Labs president Colin ...
Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.
There's little unexpected about this, especially as Genie 2, an AI model capable of generating interactive 3D environments, ...
Sir Demis Hassabis said it feels like a recognition that AI is mature enough now to help with scientific discovery. Read more at straitstimes.com.
Meanwhile, tech giants like Amazon and Microsoft are slashing their workforce amid massive spending to build and deploy new ...
Research is first initiative from Big Tech group’s AI health unit formed by ex-DeepMind co-founder Mustafa Suleyman ...
For the first of these tasks Dr Baker and his colleagues use RF diffusion, an AI model they have developed to predict a ...
The EU AI Champions Initiative is a group of about 70 financial, technology, and industrial companies that is not an ...
AI agents are reshaping IT landscapes and creating new risks. Discover 4 steps for CIOs to take control and lead with ...
Generative artificial intelligence is revolutionising research and innovation, empowering humans to push the boundaries of ...